The Prognostic Role of Tricuspid Annular Plane Systolic Excursion in Critically Ill Patients With Septic Shock
NCT ID: NCT06008067
Last Updated: 2023-08-23
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
100 participants
OBSERVATIONAL
2023-04-01
2023-07-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effects of Terlipressin on Renal Perfusion in Patients With Septic Shock
NCT04948372
Change in MAPSE During Treatment of Sepsis
NCT05634733
Thromboelastography in in Patients With Sepsis
NCT00994877
The Prognostic Impact of Right Ventricular Systolic Dysfunction on the Survival of Patients With Sepsis and Septic Shock
NCT06193109
Evolution of Muscle Function, Breathlessness and Quality of Life Following Intra or Extra-Abdominal Sepsis in ICU Patients
NCT06010186
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Survivors
Patients who survived after day 28.
tricuspid annular plane systolic excursion (TAPSE)
Echocardiography
Non-survivors
Patients who died at or before day 28.
tricuspid annular plane systolic excursion (TAPSE)
Echocardiography
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
tricuspid annular plane systolic excursion (TAPSE)
Echocardiography
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Trauma
* Documented coronary heart disease
* History of myocardial infarction
* Myocarditis
* Thrombo-embolic pulmonary disease
* Valvular heart disease
* Corpulmonale
* Arrhythmia
* Known left ventricular ejection fraction \< 40%
* Poor echocardiographic window
18 Years
64 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Alexandria University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Tamer Habib, MD
Role: PRINCIPAL_INVESTIGATOR
University of Alexandria
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Faculty of Medicine, Alexandria University Hospitals
Alexandria, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Habib T, Ahmed I, Abayazeed R, Montasser M. The prognostic role of tricuspid annular plane systolic excursion in critically ill patients with septic shock. J Anesth Analg Crit Care. 2025 Apr 30;5(1):24. doi: 10.1186/s44158-025-00227-0.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
TAPSESEPTIC
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.